NM_001382.4:c.509A>G
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_001382.4(DPAGT1):āc.509A>Gā(p.Tyr170Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,614,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001382.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DPAGT1 | NM_001382.4 | c.509A>G | p.Tyr170Cys | missense_variant | Exon 4 of 9 | ENST00000354202.9 | NP_001373.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152042Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251314Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135840
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461884Hom.: 0 Cov.: 33 AF XY: 0.0000138 AC XY: 10AN XY: 727246
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152160Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74392
ClinVar
Submissions by phenotype
Congenital disorder of glycosylation Pathogenic:1
- -
DPAGT1-congenital disorder of glycosylation Pathogenic:1
- -
not provided Pathogenic:1
Identified in trans with another DPAGT1 missense variant, p.A195G, in two siblings with abnormal neurological findings, with one sibling reported to have abnormal transferrin studies consistent with a type 1 congenital disorder of glycosylation (PMID: 26805780, 30117111); Identified in a patient with congenital disorder of glycosylation type 1j who reportedly harbored a second unknown variant in trans which resulted in decreased mRNA levels (PMID: 12872255); Published functional studies demonstrate a damaging effect: reduced N-acetyl-glucosamine-1 phosphate transferase (GPT) activity in in vitro assays (PMID: 12872255); Not observed at significant frequency in large population cohorts (gnomAD); Missense variants in this gene are often considered pathogenic (HGMD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23249953, 22304930, 22742743, 30388443, 31519321, 26805780, 30117111, 12872255) -
DPAGT1-congenital disorder of glycosylation;C3553645:Congenital myasthenic syndrome 13 Uncertain:1
Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Experimental studies have shown that this missense change affects DPAGT1 function (PMID: 12872255). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This missense change has been observed in individual(s) with congenital disorder of glycosylation 1J (CDG-Ij) (PMID: 12872255, 30117111). This variant is also known as c.660A>G. ClinVar contains an entry for this variant (Variation ID: 12296). This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 170 of the DPAGT1 protein (p.Tyr170Cys). This variant is present in population databases (rs28934876, gnomAD 0.004%). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at